Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Francisco (ucsf) - Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- University of Pennsylvania - Abramson Cancer Center
Philadelphia, Pennsylvania, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jun 2017
- Primary completion
- 24 Dec 2024
- Completion
- 31 Dec 2025
- Last update posted
- 7 Aug 2025
- Registered enrollment
- 29
- Registry id
- NCT03190278
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.